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Background
Research demonstrates a correlation between diagnosed depression and
increased markers of chronic medical illness, including poorer glycemic
control, increased risk for cardiovascular events, and obesity. Moreover,
medically underserved patient populations are especially at high risk for
poor health outcomes due to chronic illness, which has profound
implications for both individual patients as well as the healthcare system.
However, very little research has been done on chronic health outcomes
among underserved mental health patients treated in integrated
behavioral health/primary medical care settings. MedZou, a student-run,
free medical clinic provides integrated health care services to uninsured,
low-income adults in Mid-Missouri, and provides a potentially ideal
setting for this research. We wanted to compare health outcomes
between patients identified with depression and those without depression
that were treated at MedZou.
Methods
A retrospective chart review was completed on all patients seen at the
MedZou clinic from May 1, 2014 to June 1, 2015. Data from 204 unique
patients and 507 clinic visits was extracted, including demographics,
medications, past and current diagnosis and treatment, vital signs,
mental health screening, and physiological health markers (incident
glucose level, height/weight, and hemoglobin A1c) for each visit during
the 13 month period. Records with incomplete or ambiguous data were
excluded from analysis. Patients were included in the depression arm of
the study if they had any of the following criteria: (1) diagnosis of
depression, (2) positive PHQ-2 screen, or (3) pharmacologic treatment
for depression (not prescribed for headache or sleep). Patients were
included in the non-depression arm of the study if they did not meet any
of the above criteria. 87 patients (206 visits) were included in the
"depression" arm of the study while 81 patients (154 visits) were
classified into the "non-depression" arm. Data measures of mean
incident glucose, incident glucose above 200mg/dL, body mass index,
and mean hemoglobin A1c were compared between the 2 groups. Mean
number of visits per patient in each group were also analyzed. Data was
entered using RedCap software and analyzed with Microsoft Excel and
SPSS using the two-sample t-test and N-1 two proportion test.
Results
Our analysis showed a statistically significant relationship between
depression and lower incident glucose measurement (p=0.007). We
also found a statistically significant lower proportion of depressed
patients with incident glucose >200mg/dL compared to non-depressed
patients (p=0.006). While no other identified markers of health status
resulted in statistically significant findings, our results showed both
reduced BMI and reduced levels of hemoglobin A1c among patients
identified with depression compared to those without. Patients with
depression had a higher average number of visits (2.3) per patient
compared to patients without depression (1.9), although this difference
was not found to be statistically significant.
Discussion
In contrast to previously published findings, our results showed
improved glycemic control and lower proportions of incidentally
diagnosed diabetes among patients with depression. Although the
findings for other outcome measures were not statistically significant,
they trended in a similar direction with depressed patients having lower
mean body mass index and hemoglobin A1c levels. While these findings
could be due to unidentified confounding factors, there is also a notable
trend of increased number of visits for individuals with incident
depression diagnosis.This may indicate an increased frequency of care
provided to patients with depression at MedZou, which may have
contributed to these outcomes. However, these findings may also be
attributable to a lack of statistical power given the size of our sample, o r
reflect other unidentified factors that are positively affecting health
outcomes in this population. Further research is recommended to
expound on and characterize these findings. Additionally, it is clear that
improving capture of both mental illness diagnoses in a patient visit as
well as systematic monitoring of markers of chronic illness would
improve data quality for future studies of correlations between mental
illness and health outcomes.
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